Nucleosome Epigenetic Analysis via Enzymatic Labeling and TIRF Imaging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for early cancer detection, particularly for late-stage cancers, lack effective non-invasive screening options and have limitations in sensitivity and dynamic range when analyzing nucleosomes and plasma proteins, as they often require large amounts of material and are costly, focusing mainly on genetic mutations rather than epigenetic modifications.
Innovation Solution
A method involving the isolation of nucleosome molecules from biological samples, enzymatic labeling with adenine nucleotides, hybridization to a solid support, and imaging using Total Internal Reflection (TIRF) microscopy to visualize and analyze histone modifications and nucleosome patterns, enabling high-resolution, multiplexed analysis of epigenetic markers in small plasma samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of information
If deep sequencing or ChIP-seq is used to analyze cfNucleosomes, then comprehensive epigenetic information can be obtained, but the cost increases and the requirement for large amounts of input material is not met
Solution Approach 1:
The patent extracts and enriches cfNucleosomes from plasma samples through selective immunoprecipitation using antibodies against specific histone modifications. This extraction approach concentrates the epigenetic information of interest from a complex biological mixture, enabling subsequent analysis with limited sample material while avoiding the need for deep sequencing of entire genomes.
Solution Approach 2:
The patent introduces an intermediary enrichment step using histone modification-specific antibodies as mediators between the cfNucleosomes and the detection system. These antibodies selectively bind to and enrich specific epigenetic marks, allowing comprehensive epigenetic information to be obtained from small plasma volumes without requiring expensive deep sequencing approaches.
2Measurement precision
If ChIP-seq is used to measure histone modifications, then epigenetic marks can be identified, but the dynamic range is limited and large amounts of input material are required
Solution Approach 1:
The patent segments the analysis by dividing it into distinct enrichment and detection phases. First, cfNucleosomes are selectively enriched through immunoprecipitation with histone modification-specific antibodies. Then, the enriched material is analyzed using a sensitive detection method. This segmentation allows precise measurement of histone modifications from small input volumes by concentrating the target analytes before detection.
Solution Approach 2:
The patent replaces the mechanical shearing and extensive processing required by traditional ChIP-seq with a more efficient immunoprecipitation-based enrichment system. This substitution uses biochemical specificity of antibodies to directly isolate modified histones, achieving better measurement precision with less input material and simplified procedures.
3Device complexity
If single-layer analysis (single histone modification or DNA methylation) is performed, then the methodology is simple, but the sensitivity and resolution are limited
Solution Approach 1:
The patent creates a universal platform that can detect multiple layers of epigenetic information (different histone modifications, DNA methylation patterns) through a common immunoprecipitation and detection workflow. By using a panel of antibodies against different histone marks and combining with methylation analysis, the system achieves high-sensitivity multi-parametric detection while maintaining operational simplicity through standardized procedures.
Solution Approach 2:
The patent employs a composite analytical approach that combines multiple detection modalities (immunoprecipitation, fluorescence detection, sequencing) within a single integrated workflow. This composite methodology analyzes multiple epigenetic layers simultaneously, achieving high sensitivity and resolution while keeping the overall process manageable through systematic integration of different technical components.
4Reliability
If existing screening tests are used for cancer detection, then some cancer types can be screened, but the efficacy is limited and many patients do not follow screening guidelines
Solution Approach 1:
The patent changes the detection parameters from genetic mutations to epigenetic modifications (histone modifications, DNA methylation) that are present in cfNucleosomes. These epigenetic parameters provide tissue-specific and cancer-type-specific patterns that enhance detection efficacy across multiple cancer types. The approach detects epigenetic signatures that differ between healthy and cancerous tissues, improving reliability while being adaptable to various cancer origins.
Solution Approach 2:
Instead of analyzing intact cells or tissues through invasive procedures, the patent inverts the approach by analyzing fragmented cfNucleosomes that have been released into the plasma. This inversion enables non-invasive detection of cancer-specific epigenetic patterns, improving both reliability of detection and versatility across different cancer types without requiring patients to undergo invasive screening procedures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for sensitive and quantitative detection of cancer-specific epigenetic modifications, enabling accurate diagnosis of colorectal cancer and other diseases at early stages with minimal sample volume, providing multi-layered clinical information for improved cancer diagnostics.
Implementation Method 1
enzymatically linking adenine nucleotides to free DNA ends of the plurality of nucleosome molecules
Implementation Method 2
hybridizing the plurality of nucleosome molecules attached to the labeled poly(A) tail to a solid support coated with poly(T)
Implementation Method 3
imaging the solid support, whereby the plurality of nucleosome molecules are visualized
Data Source
AI summary
A method of analyzing nucleosomes is provided. The method comprising: (a) isolating a plurality of nucleosome molecules from a biological sample; (b) enzymatically linking adenine nucleotides to free DNA ends of the plurality of nucleosome molecules, wherein at least a portion of the adenine nucleotides comprises a label, such that the plurality of nucleosome molecules become attached to a labeled poly(A) tail; (c) hybridizing the plurality of nucleosome molecules attached to the labeled poly(A) tail to a solid support coated with poly(T); and (d) imaging the solid support, whereby the plurality of nucleosome molecules are visualized.